首页 | 本学科首页   官方微博 | 高级检索  
检索        


Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants
Institution:1. Department of Medical Epidemiology and Biostatistics, Campus Solna, Karolinska Institutet, Stockholm, Sweden;2. Clinical Epidemiology Unit/Clinical Pharmacology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden;3. Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden;4. Department of Clinical Science Intervention and Technology, Hospital Huddinge, Karolinska University, Huddinge, Sweden;5. Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy;6. Department of Medicine and Health Research Methods, Evidence and Impact, McMaster University, Ontario, Canada;7. Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts;8. Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands
Abstract:
><ol class=
  • Download : Download high-res image (408KB)
  • Download : Download full-size image
  • Keywords:Acute kidney injury (AKI)  apixaban  atrial fibrillation (AF)  chronic kidney disease (CKD)  CKD progression  creatinine  direct oral anticoagulants (DOAC)  effectiveness  renal failure  safety  SCREAM  vitamin K antagonists (VKA)  warfarin
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号